Email Addresses - JE Part A
Email Addresses
Do you have Medicare claims questions?
Providers may email Noridian [complete/submit Contact Us Form] general Medicare inquiries regarding regulations and coverage. NOTE: Allow up to 45 business days to receive a response on postal and/or email submitted inquiries.
For a quicker inquiry response, contact our Provider Contact Center to speak directly with a Customer Service Representative.
Beneficiaries must contact Medicare by calling 1-800-MEDICARE (1-800-633-4227).
Topic Specific Email Addresses
If you are seeking an answer to a topic specific question, providers may email the below for the intended purposes only. Emailing us for a reason not described below will cause response delays.
Do not email us Confidential information as it is possible for others to view the email contents, exposing you or others as a target for fraud or abuse. This includes private information such as patient names, claim information, Medicare IDs, Social Security Numbers (SSNs), Claim Control Numbers (CCNs) or provider numbers. If you have a question that contains confidential information, contact our Provider Contact Center.
NOTE: Allow up to 45 business days to receive a response on postal and/or email submitted inquiries.
Correspondence | When To Use This Address | Email Address |
---|---|---|
LCD Reconsideration Request |
Use this address to request a revision to an existing LCD. Emails sent to this address require specific information. Review the LCD Reconsideration Process webpage for a full listing of required items to include. |
mpreconsideration@noridian.com |
LCD: New LCD Request |
Use this address to request the creation of a new LCD. Emails sent to this address require specific information. Review the New LCD Request Process webpage for a full listing of required items to include. |
mpreconsideration@noridian.com |
Website Questions | Use this form to report website ease of use or difficulties. | Website Feedback Form |
CMS Comments on Noridian | Use this contact information to send comments to CMS concerning Noridian's performance. | CMS Contact |